The Effects of Checkpoint Blockade and a CD40 Agonist on Tindependent and T-Dependent Antibody Responses in Mice: Implications for Optimization of Vaccination Strategies in Patients Receiving Immunotherapies

Journal of Cancer Research and Immuno-Oncology
doi 10.35248/2684-1266.18.4.115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Longdom Group

Related search

Current Status of Chimeric Antigen Receptor Engineered T Cell-Based and Immune Checkpoint Blockade-Based Cancer Immunotherapies

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2017English

CD40/anti-CD40 Antibody Complexes Which Illustrate Agonist and Antagonist Structural Switches

BMC Molecular and Cell Biology
Cell BiologyMolecular Biology
2019English

TNF Blockade Impairs T Cell Dependent Humoural Responses

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Heterologous Vaccination and Checkpoint Blockade Synergize to Induce Antileukemia Immunity

Journal of Immunology
AllergyImmunology
2016English

GITR Agonist Enhances Vaccination Responses in Lung Cancer

OncoImmunology
OncologyAllergyImmunology
2015English

Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies

Lung Cancer Management
2018English

Humoral Immune Responses in CD40 Ligand-Deficient Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1994English

Antibody Distribution and Dosimetry in Patients Receiving Radiolabelled Antibody Therapy for Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

CD4+ CD25+ Regulatory T Cells Modulate the T-Cell and Antibody Responses in Helicobacter-Infected BALB/c Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy